BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 172392)

  • 21. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediation of serum-induced changes in cyclic nucleotide levels in cultured fibroblasts by cyclic nucleotide phosphodiesterase.
    Pledger WJ; Thompson WJ; Strada SJ
    Nature; 1975 Aug; 256(5520):729-31. PubMed ID: 168501
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
    Maurice DH
    Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative.
    Sakai T; Okano T; Makino H; Tsudzuki T
    J Cyclic Nucleotide Res; 1976; 2(3):163-70. PubMed ID: 180065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial purification and characterization of adenosine- and guanosine-3',5'-monophosphate phosphodiesterases from human lung tissue.
    Bergstrand H; Lundquist B
    Biochemistry; 1976 Apr; 15(8):1727-35. PubMed ID: 178354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
    Whitson RH; Appleman MM
    Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
    Minneman KP; Iversen LL
    Nature; 1976 Mar; 260(5546):59-61. PubMed ID: 177878
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW; Kuo JF
    Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic nucleotide phosphodiesterases, insulin and thyroid hormones.
    Correze C; Auclair R; Nunez J
    Mol Cell Endocrinol; 1976; 5(1-2):67-79. PubMed ID: 182575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth.
    Dumas MY; Fanidi A; Pageaux JF; Courion C; Nemoz G; Prigent AF; Pacheco H; Laugier C
    Endocrinology; 1988 Jan; 122(1):165-72. PubMed ID: 2446855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cyclic nucleotide phosphodiesterase in the rat. Kinetic properties and changes with age.
    Purvis K; Olsen A; Barry M; Hansson V
    Arch Androl; 1981 Jun; 6(4):327-35. PubMed ID: 6264877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphate.
    Ross PS; Manganiello VC; Vaughan M
    J Biol Chem; 1977 Feb; 252(4):1448-52. PubMed ID: 190234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotide phosphodiesterases of Hyalophora cecropia silkmoth fat body.
    Filburn CR; Karn J; Wyatt GR
    Biochim Biophys Acta; 1977 Mar; 481(1):152-63. PubMed ID: 14689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.